protein intake on tirzepatide reduces food and appetite, and affects brain functioning, more than placebo and liraglutide While taking Mounjaro (tirzepatide) for

Peptides such as BPC-157 and TB-500 are: Not FDA approved for treatment of any disease For research purposes only Intended for use under the supervision of a licensed, peptide-trained provider Only available to current patients All protocols are provided strictly for educational and informational purposes and should not be used without medical guidance

Semaglutide is a low-risk, effective method for short-term weight reduction

Healthcare at Internet Scale What the OpenLoop lawsuit reveals about centralized clinical infrastructure and distributed harm If you were like: Man, one wild health-tech lawsuit alleging a series of shell companies is fun, but I wish there were two, well, today is your lucky day

Conversely, a recent report by Virmani et al